Rami Katkhuda Profile - LifeSci Capital Analyst

200 Followers
tipranks
Rami Katkhuda

Rami Katkhuda
LifeSci Capital

Wall Street Analyst
#288 out of 10,109 Wall Street Analysts
#786 out of 42,308 experts

Success Rate

56%
116 out of 206 ratings made a profit

Average Return

+31.10%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Rami Katkhuda's trades since 2023 and holding each position for 1 Year would result in 56.31% of your transactions generating a profit, with an average return of 31.1% per rating.

Stock Rating Distribution

281Ratings
97.86% Buy
2.14% Hold
0.00% Sell
Distribution of Rami Katkhuda's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Moonlake Immunotherapeutics
(MLTX)
Rating:Buy
Date:Dec 21, 2022 - Dec 21, 2023
Return:+496.20%
The most profitable rating made by Rami Katkhuda

Rami Katkhuda's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CINC
Cincor Pharma
Jan 09, 2023
Hold
Initiated
5Ratings
100%
+2.30%
CALT
Calliditas Therapeutics
May 28, 2024
Hold
Downgraded
25Ratings
45%
+8.45%
VYNE Therapeutics
Aug 14, 2025
Hold
Reiterated
22Ratings
7%
-65.62%
TRML
Tourmaline Bio
Sep 09, 2025
Hold
Downgraded
$48.00
(0.04% Upside)
8Ratings
100%
+172.92%
Akero Therapeutics
Oct 09, 2025
Hold
Downgraded
$58.00
(6.89% Upside)
11Ratings
100%
+45.37%
Inventiva
Oct 09, 2025
Buy
Reiterated
$14.00
(271.35% Upside)
9Ratings
43%
+4.87%
Viridian Therapeutics
Nov 03, 2025
Buy
Reiterated
$46.00
(61.86% Upside)
38Ratings
52%
+5.85%
MoonLake Immunotherapeutics
Nov 05, 2025
Buy
Reiterated
$16.00
(28.10% Upside)
32Ratings
38%
+21.23%
Vera Therapeutics
Nov 05, 2025
Buy
Reiterated
$70.00
(149.73% Upside)
30Ratings
55%
+67.72%
Dianthus Therapeutics
Nov 06, 2025
Buy
Reiterated
$65.00
(81.41% Upside)
18Ratings
64%
+20.67%
List of latest recommendations made by Rami Katkhuda. Click to expand and see Rami Katkhuda's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Rami Katkhuda activity FAQ

What is the performance of Rami Katkhuda's recommendations?
The percentage of profitable recommendations made by Rami Katkhuda is 56%, and the average return per transaction is 31.10%.
    What stocks does Rami Katkhuda cover?
    Rami Katkhuda mostly covers VRDN ,ELDN ,MLTX stocks.
      What was Rami Katkhuda's most profitable rating?
      Rami Katkhuda’s most profitable ratings was a buy on MLTX stock on Dec 21, 2022 - Dec 21, 2023. The return on the trade was +496.20%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here